MD Anderson and TriSalus Life Sciences announce strategic research collaboration to evaluate treatment of solid tumors

(University of Texas M. D. Anderson Cancer Center) MD Anderson and TriSalus announced a strategic research collaboration to evaluate the treatment of liver and pancreas tumors with the investigational therapy SD-101 in combination with immunotherapy using a novel delivery approach.